SCHEMBL6604689

SCHEMBL6604689

CCOc1cc(C2=NN(C(=O)c3cccc(NC(=O)c4c[nH]cn4)c3)CCC2)ccc1OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
LMNA P02545 2/20 0.45
PKM P14618 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
PGR P06401 5/20 0.41
CFTR P13569 1/20 0.41
MAPT P10636 2/20 0.41
KMT2A Q03164 2/20 0.40
MAOB P27338 1/20 0.39
POLB P06746 2/20 0.39
CREBBP Q92793 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6600797 0.95 ALDH1A1 (0.48) ALDH1A1LMNAPKMNPSR1SMN1; SMN2
SCHEMBL6607064 0.92 CFTR (0.45) ALDH1A1LMNASMN1; SMN2PGRCFTR
SCHEMBL6603487 0.89 PDE5A (0.46) ALDH1A1LMNAPKMNPSR1SMN1; SMN2
SCHEMBL6602816 0.89 NPC1 (0.48) ALDH1A1LMNAPKMNPSR1SMN1; SMN2
SCHEMBL6583372 0.88 ALDH1A1 (0.52) ALDH1A1LMNAPKMNPSR1SMN1; SMN2
SCHEMBL6582371 0.88 NPC1 (0.49) ALDH1A1LMNAPKMNPSR1SMN1; SMN2
SCHEMBL6603283 0.87 ALDH1A1 (0.43) ALDH1A1LMNAPKMNPSR1SMN1; SMN2
SCHEMBL6583492 0.87 ALDH1A1 (0.51) ALDH1A1LMNAPKMNPSR1SMN1; SMN2
SCHEMBL6585171 0.87 ALDH1A1 (0.55) ALDH1A1LMNAPKMNPSR1SMN1; SMN2
SCHEMBL6601223 0.87 ALDH1A1 (0.44) ALDH1A1LMNAPKMNPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0922036-B1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GMBH (DE) 2004-03-24 EP disclosed
US-6479494-B1 THEY INHIBIT SELECTIVELY PHOSPHODIESTERASE IV, WHICH CAUSES AN INCREASE OF THE INTRACELLULAR CAMP LEVEL AS CAMP INHIBITS BONE DECREASING CELLS AND STIMULATES BONE INCREASING CELLS FOR TREATMENT OF OSTEOPOROSIS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2002-11-12 US disclosed
US-6107295-A Arylalkanoyl pyridazines MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-08-22 US disclosed
EP-0922036-A1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GmbH (DE) 1999-06-16 EP disclosed
WO-1998006704-A1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GMBH (DE) 1998-02-19 WO disclosed